BioFocus DPI and Medicines for Malaria Venture collaborate to identify anti-malarial compounds
20-Apr-2009
- Switzerland
Prior to the collaboration, MMV had acquired access to BioFocus DPI’s natural product and SoftFocus® compound collections, which gave hits with anti-malarial activity in disease-specific assays. The aim of the current collaboration is to determine which of the small molecules in these collections show activity, with the intention to further optimize these hits as anti-malarial therapeutics.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.